Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?

Bone marrow transplantation - 1 Jan 2005

Kallianpur A R

Abstract excerpt

The occurrence of toxic complications following hematopoietic stem cell transplantation (HSCT) is highly variable and dependent on a multitude of host, donor, and treatment factors. The increasingly broad indications for HSCT and the need to provide this treatment option to older and/or more debilitated patients emphasizes the importance of refining our methods of predicting and ameliorating these toxicities....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Graft Survival
Share to Graft vs Host Disease
Share to Lung Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mass Screening

Share to Methotrexate

Share to Oxidants

Share to Renal Insufficiency

Share to Transplantation Conditioning

Source

Identifiers

PMID: 15489868
DOI: 10.1038/sj.bmt.1704716

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic screening and complications of hematopoietic stem cell transplantation: has the time come?PMID 15489868Read ↗

Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS/VOD after haematopoietic cell transplantationSemantic proximity Read ↗

Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipientsSemantic proximity Read ↗

Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation.Semantic proximity Read ↗

Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?Semantic proximity Read ↗

New directions in the genomics of allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome?Semantic proximity Read ↗

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?Semantic proximity Read ↗

Incidence and risk factors of early onset VOD/SOS differ in younger vs older adults after stem cell transplantationSemantic proximity Read ↗

The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.Semantic proximity Read ↗

Glutathione S-Transferase M1 polymorphism – A risk factor for hepatic venoocclusive disease in bone marrow transplantationSemantic proximity Read ↗

Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.